BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23829392)

  • 1. Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma.
    Lee SS; Jeong SH; Byoun YS; Chung SM; Seong MH; Sohn HR; Min BY; Jang ES; Kim JW; Park GJ; Lee YJ; Lee KH; Ahn S
    BMC Cancer; 2013 Jul; 13():335. PubMed ID: 23829392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].
    Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK
    Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma].
    Rim MY; Kwon OS; Ha M; Kim JS; Ko KI; Kim DK; Jang PK; Han JY; Park PH; Jung YK; Choi DJ; Kim YS; Kim JH
    Korean J Gastroenterol; 2014 May; 63(5):292-8. PubMed ID: 24870301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Liew ZH; Goh GB; Hao Y; Chang PE; Tan CK
    Dig Dis Sci; 2019 Feb; 64(2):585-590. PubMed ID: 30327962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
    Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
    J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
    Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
    J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of liver cirrhosis over ten consecutive years in Southern China.
    Wang X; Lin SX; Tao J; Wei XQ; Liu YT; Chen YM; Wu B
    World J Gastroenterol; 2014 Oct; 20(37):13546-55. PubMed ID: 25309085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Positive Hepatitis B Core Antibody and Metabolic Disorders in Hepatocellular Carcinoma in an Endemic Area of Hepatitis B Virus.
    Lee HL; Bae SH; Lee J; Sung PS; Lee SW; Jang JW; Lee J; Choi JY; Han NI; Yoon SK
    Cancer Control; 2021; 28():10732748211039758. PubMed ID: 34569320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
    Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
    Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
    Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
    Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease.
    Than NN; Ghazanfar A; Hodson J; Tehami N; Coldham C; Mergental H; Manas D; Shah T; Newsome PN; Reeves H; Shetty S
    QJM; 2017 Feb; 110(2):73-81. PubMed ID: 27634970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan.
    Tokushige K; Hashimoto E; Kodama K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
    Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
    Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of development of hepatocellular carcinoma in patients with NASH-related cirrhosis.
    Amarapurkar DN; Dharod M; Gautam S; Patel N
    Trop Gastroenterol; 2013; 34(3):159-63. PubMed ID: 24851525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease.
    Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY
    J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
    Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes.
    Yen YH; Kuo FY; Eng HL; Liu YW; Yong CC; Wang CC; Li WF; Lin CY
    Updates Surg; 2024 Jun; 76(3):879-887. PubMed ID: 38582796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
    Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
    Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.